The SAHPRA Playbook: What Biotech Startups Need to Know

Biotech startups developing health technologies must navigate complex regulatory pathways to bring their innovations to market. This panel discussion with representatives from the South African Health Products Regulatory Authority (SAHPRA) will explore how biotech startups can engage with regulators, understand approval processes, and plan their development strategies with regulatory requirements in mind.

Join us for an open conversation on translating scientific discoveries into safe, approved health products in South Africa, with practical insights for early-stage innovators working on therapeutics, diagnostics, and other biomedical technologies.

*This event is limited to 40 guests to ensure maximum engagement between the audience and panelists

Panelists:

Dr Dimakatso Mathibe (Senior Manager: Medical Devices and Radiation Control)

Ms Siverani Padayachee (Senior Manager: Pharmaceutical Evaluation Management)

Who Should Attend

• Biotech startups and entrepreneurs seeking to understand the regulatory pathways
• Academics and researchers exploring commercialization
• Industry partners & collaborators

Outcomes for Participants

Attendees will leave with:

• A clearer understanding of the SAHPRA regulatory playbook
• Practical insights into how the body operates
• Valuable connections within South Africa’s biotech innovation ecosystem